Cargando…
Hepatitis C Virus Reactivation Following COVID-19 Vaccination – A Case Report
PURPOSE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection impacted morbidity and mortality during the pandemic of 2020–2021. A number of anti-COVID-19 vaccines have been developed with an unprecedented speed. While these vaccines have good efficacy and are safe, the experience...
Autores principales: | Lensen, Ruud, Netea, Mihai G, Rosendaal, Frits R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412816/ https://www.ncbi.nlm.nih.gov/pubmed/34512037 http://dx.doi.org/10.2147/IMCRJ.S328482 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Hepatitis c virus reactivation: case report
Publicado: (2021) -
Hepatitis C Virus Reactivation Following COVID-19 Vaccination – A Case Report [Corrigendum]
Publicado: (2021) -
Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports
por: Mohamed, Libin, et al.
Publicado: (2021) -
Fulminant hepatitis following COVID‐19 vaccination: A case report
por: Barary, Mohammad, et al.
Publicado: (2022) -
Reactivation of herpes simplex keratitis following vaccination for COVID-19
por: Richardson-May, James, et al.
Publicado: (2021)